A new Nature Communications study demonstrates that Predicine’s cfDNA methylation technology identified clinical response more than 3 months before standard imaging & stratified baseline risk View Publication lnkd.in/gcm_GQCA Schedule a meeting lnkd.in/gJfc8QBw

At AACR 2026, Predicine liquid biopsy technology will be featured in 13 presentations - including 1 oral presentation & 12 posters focusing on targeted therapy, ADCs, synthetic lethality, & immunotherapy. Booth#2045 Onsite: lnkd.in/gfAgtgmy Online: lnkd.in/gJfc8QBwLearn

New data at #ASCOGU Today, Predicine is presenting six studies advancing integrated blood and urine liquid biopsy across the cancer care continuum. 📍 Visit us at Booth #54 📅 Schedule a meeting with our team:  outlook.office.com/book/Meet…

Stop by Booth #54 tomorrow to meet the Predicine team and learn how innovation in blood and urine liquid biopsy is advancing precision care in prostate cancer, bladder cancer, and renal cell carcinoma. 📅 Schedule time with our team: outlook.office.com/book/Meet…

Predicine is excited to present 6 posters at ASCO GU 2026 and host our Global Networking Reception in San Francisco on Thursday, February 26. 2026 at 6:30 PM PST. 📅 Schedule a meeting with our team outlook.office.com/book/Meet… RSVP for the reception! lnkd.in/gkJruU4C

Meet Predicine at 10th LBx for Precision Oncology Summit! February 3-5, 2026 | San Diego Dr. Shidong Jia, Predicine's CEO, will present “KRAS & Beyond: Integrated Liquid Biopsy & MRD Solutions for Global Oncology Drug Development” Schedule a meeting: lnkd.in/gEYECiUb

Meet Predicine at ASCO GI in San Francisco on January 12–15, 2026 (Booth #26). Explore how our Accurate, Accessible, & Affordable liquid biopsy solutions accelerate biomarker discovery, global clinical trials, CDx development, and commercialization. outlook.office.com/book/Meet…

Join Predicine (booth #1543) at SABCS 2025 in San Antonio, Texas, from December 9–12! 📅 Schedule a meeting: outlook.office.com/book/Meet…

Join Predicine at ASH 2025 in Orlando, Florida, from December 6–9! Booth #156 Abstract: Evaluation of factors from established prognostic models in patients with chronic lymphocytic leukemia treated with zanubrutinib 📅 Schedule a meeting: outlook.office.com/book/Meet…

Join Predicine at SUO 2025 in Phoenix, Arizona, from December 2–5! Visit us at our booth to discover our groundbreaking urinary liquid biopsy solutions, delivering powerful insights through genomic profiling and MRD detection. 📅 Schedule a meeting: outlook.office.com/book/Meet…

As part of Predicine’s 10-year anniversary global celebration series, we are delighted to host the Predicine Liquid Biopsy Summit 2025 - South San Francisco! RSVP: eventbrite.com/e/predicine-l… Join us for a lunch and lab tour to Predicine in Hayward eventbrite.com/e/predicine-l…

At SITC 2025, Predicine is showcasing how its’ comprehensive & ultra-sensitive liquid biopsy solutions accelerate global biomarker-driven drug development, including our harmonized genomics & genetics platform in China. Meet with us at booth #816 outlook.office.com/book/Meet…

See New Groundbreaking Predicine Data at ESMO 2025 - Booth #2035 Predicine is proud to present 3 ctDNA studies that highlight our cutting-edge innovations in liquid biopsy. 📅 Schedule a meeting with our team (in-person or virtual): outlook.office.com/book/Meet…

Join us at the Predicine Liquid Biopsy Summit 2025 – Shanghai, Predicine’s Global 10th Anniversary Celebration • Date: October 25, 2025 (Saturday) • Time: 9:00 AM - 3:00 PM (GMT +8) • Venue: JW Marriott Hotel Shanghai, Tomorrow Square, Shanghai, China eventbrite.com/e/predicine-l…

Visit Predicine at Booth #6 Predicine will share its integrated, multi-omic profiling data in liquid biopsy to enable faster, data-driven decisions in RAS-targeted clinical development. • Schedule a 1:1 with our team: outlook.office.com/book/Meet…

Join Predicine at WCLC 2025 at booth #105! 📑 Featured Poster: Longitudinal ctDNA Profiling in HER2-Altered NSCLC Treated With HER2 ADC: Preliminary Results From the RESOLUTION Trial Learn more: cattendee.abstractsonline.co… 🔗 Schedule a meeting: lnkd.in/grdVE6B8

Today we’re proud to share that Predicine has officially submitted the first module of its PMA application to the FDA for PredicineCARE™, a urine cfDNA NGS assay, as a companion diagnostic (CDx) for bladder cancer. globenewswire.com/news-relea…

On Day 4 of #ASCO25, visit Predicine at Booth #14095 to discover how our AAA solutions accelerate biomarker discovery, boost trial efficiency, and advance precision oncology. RSVP for the Predicine Global Networking Reception tonight, June 2 at 6:00 PM: eventbrite.com/e/predicine-g…

Stop by Predicine Booth #14095 to explore how Predicine’s liquid biopsy platforms deliver comprehensive genomic and epigenomic insights, driving non-invasive, real-time tumor profiling. 🎉 RSVP for the Predicine Global Networking Event on June 2: eventbrite.com/e/predicine-g…

Join us at ASCO 2025! Discover how Predicine is driving the future of precision oncology with 8 cutting-edge ctDNA studies! 📍 Visit us at Predicine Booth #14095 🎉 RSVP for the Predicine Global Networking Event: @ASCO25 Mon, Jun 2, 2025 at 6:00 PM | lnkd.in/gem36iFj